Welcome to our dedicated page for SHF Holdings SEC filings (Ticker: SHFS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cannabis banking is complicated. SHF Holdings’ disclosures mix traditional financial metrics with the added layers of Bank Secrecy Act controls, FinCEN guidance and state-by-state cannabis legislation. Hunting for loan concentration tables or changes in consent-order language across 200+ pages can slow even seasoned analysts.
Stock Titan solves that problem. Our AI reads every SHF Holdings quarterly earnings report 10-Q filing and flags shifts in deposit growth, compliance costs and contingent liabilities in plain English. Need real-time alerts when directors buy shares? You’ll see SHF Holdings insider trading Form 4 transactions within minutes of EDGAR release, plus concise context from our models.
Use this page to access every filing type, updated the moment it posts:
- 10-K and SHF Holdings annual report 10-K simplified summaries that spotlight cannabis-specific risk factors and revenue by fee streams.
- Interactive tables inside each 10-Q for quarter-over-quarter trend analysis––perfect for quick SHF Holdings earnings report filing analysis.
- 8-K event briefs so SHF Holdings 8-K material events explained makes sense in seconds.
- Proxy insights on governance and SHF Holdings proxy statement executive compensation.
- SHF Holdings Form 4 insider transactions real-time monitoring to follow executive sentiment.
Whether you’re understanding SHF Holdings SEC documents with AI for due diligence or comparing bank-fee revenue trends, you’ll find every detail here—already distilled, linked and ready for action.
VirnetX Holding Corp. (VHC) filed a Form 4 reporting an automatic, non-discretionary insider transaction by Chief Scientist Robert D. Short III on 07/07/2025. The company withheld 50 common shares (Transaction Code F) at a price of $12.34 to satisfy payroll and income-tax obligations linked to previously granted restricted stock awards. The explanatory note confirms the transaction is strictly for tax settlement and does not involve an open-market sale.
Post-transaction ownership stands at 31,848 direct shares and 11,278 indirect shares held through The Short Revocable Living Trust, leaving Short’s overall economic exposure essentially unchanged. No derivative securities were exercised, acquired, or disposed of, and no other insider activity was disclosed. Given the immaterial size (≈0.1 % of Short’s total holdings) and its administrative nature, the filing carries limited investment significance and signals no shift in insider sentiment toward VirnetX.